{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:37:05Z","timestamp":1792175825613,"version":"4.4.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.cgh.2022.08.033","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T04:47:51Z","timestamp":1662439671000},"page":"2707-2716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review"],"prefix":"10.1016","volume":"20","author":[{"given":"Steven L.","family":"Flamm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7888-1165","authenticated-orcid":false,"given":"Patrick S.","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2022.08.033_bib1","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ajg.2017.122","article-title":"Acute kidney injury in cirrhosis: Baseline serum creatinine predicts patient outcomes","volume":"112","author":"Wong","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2022.08.033_bib2","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jhep.2020.08.037","article-title":"Natural history of acute kidney disease in patients with cirrhosis","volume":"74","author":"Tonon","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.08.033_bib3","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/03007995.2017.1331211","article-title":"The burden of hepatorenal syndrome among commercially insured and Medicare patients in the United States","volume":"33","author":"Rice","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.cgh.2022.08.033_bib4","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2011.10.016","article-title":"Renal failure and cirrhosis: a systematic review of mortality and prognosis","volume":"56","author":"Fede","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.08.033_bib5","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/hep.30859","article-title":"Incidence, Risk factors, and outcomes of transition of acute kidney injury to chronic kidney disease in cirrhosis: a prospective cohort study","volume":"71","author":"Maiwall","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.08.033_bib6","first-page":"8","article-title":"KDIGO Clinical Practice Guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.cgh.2022.08.033_bib7","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/hep.29303","article-title":"Significance of oliguria in critically ill patients with chronic liver disease","volume":"66","author":"Amathieu","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.08.033_bib8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.25735","article-title":"TRIBE-AKI Consortium. Association of AKI with mortality and complications in hospitalized patients with cirrhosis","volume":"57","author":"Belcher","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.08.033_bib9","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1053\/j.gastro.2013.08.051","article-title":"North American Consortium for Study of End-Stage Liver Disease. New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection","volume":"145","author":"Wong","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.08.033_bib10","doi-asserted-by":"crossref","first-page":"m2687","DOI":"10.1136\/bmj.m2687","article-title":"Hepatorenal syndrome: pathophysiology, diagnosis, and management","volume":"370","author":"Simonetto","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2022.08.033_bib11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Angeli","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.08.033_bib12","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.08.033_bib13","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2022.08.033_bib14","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jhep.2018.08.006","article-title":"Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial","volume":"69","author":"Sol\u00e0","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.08.033_bib15","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jhep.2020.08.021","article-title":"On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites","volume":"74","author":"Caraceni","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.08.033_bib16","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa2022166","article-title":"ATTIRE Trial Investigators. A randomized trial of albumin infusions in hospitalized patients with cirrhosis","volume":"384","author":"China","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2022.08.033_bib17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jhep.2016.10.024","article-title":"New diagnostic criteria and management of acute kidney injury","volume":"66","author":"Wong","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.08.033_bib18","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.4254\/wjh.v8.i34.1497","article-title":"Fractional excretion of sodium in hepatorenal syndrome: Clinical and pathological correlation","volume":"8","author":"Alsaad","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1016\/j.cgh.2022.08.033_bib19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hep.29772","article-title":"Fractional excretion of urea: a simple tool for the differential diagnosis of acute kidney injury in cirrhosis","volume":"68","author":"Patidar","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.08.033_bib20","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/lt.26216","article-title":"Estimating glomerular filtration rate in cirrhosis using creatinine-based and cystatin C-based equations: systematic review and meta-analysis","volume":"27","author":"Singapura","year":"2021","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2022.08.033_bib21","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/lt.26275","article-title":"Estimating glomerular filtration rate in cirrhosis: a variable science that needs clinical awareness","volume":"27","author":"Gullaro","year":"2021","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2022.08.033_bib22","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jhep.2016.05.025","article-title":"Kidney biomarkers in cirrhosis","volume":"65","author":"Francoz","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.08.033_bib23","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2215\/CJN.09430913","article-title":"Urinary biomarkers and progression of AKI in patients with cirrhosis","volume":"9","author":"Belcher","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cgh.2022.08.033_bib24","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1053\/j.ajkd.2020.03.016","article-title":"Clinical application of kidney biomarkers in cirrhosis","volume":"76","author":"Allegretti","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cgh.2022.08.033_bib25","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1111\/liv.15069","article-title":"Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome","volume":"41","author":"Sol\u00e9","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2022.08.033_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.30592","article-title":"Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis: a prospective study","volume":"70","author":"Huelin","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.08.033_bib27","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000359","article-title":"HRS-HARMONY study investigators. Urinary NGAL as a diagnostic and prognostic marker for acute kidney injury in cirrhosis: a prospective study","volume":"12","author":"Allegretti","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.cgh.2022.08.033_bib28","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","article-title":"International Club of Ascites. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2022.08.033_bib29","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2022.08.033_bib30","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/apt.14052","article-title":"Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies","volume":"45","author":"Sanyal","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2022.08.033_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12876-015-0389-9","article-title":"Albumin treatment regimen for type 1 hepatorenal syndrome: a dose-response meta-analysis","volume":"15","author":"Salerno","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cgh.2022.08.033_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135625","article-title":"Creatinine change on vasoconstrictors as mortality surrogate in hepatorenal syndrome: systematic review & meta-analysis","volume":"10","author":"Belcher","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2022.08.033_bib33","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"TAHRS Investigators. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Mart\u00edn-Llah\u00ed","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.08.033_bib34","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A\u00a0randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.08.033_bib35","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"REVERSE Study Investigators. Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1","volume":"150","author":"Boyer","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.08.033_bib36","first-page":"S326","article-title":"Increased incidence of respiratory failure with terlipressin use in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure","volume":"75","author":"Wong","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.08.033_bib37","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion vs intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.08.033_bib38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2010.11.020","article-title":"Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics","volume":"55","author":"Boyer","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.08.033_bib39","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.cgh.2018.01.035","article-title":"European Foundation for the Study of Chronic Liver Failure (EF Clif). Association between grade of acute on chronic liver failure and response to terlipressin and albumin in patients with hepatorenal syndrome","volume":"16","author":"Piano","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.08.033_bib40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23283","article-title":"Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome","volume":"51","author":"Nazar","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.08.033_bib41","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/liv.14037","article-title":"Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival","volume":"39","author":"Sol\u00e9","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2022.08.033_bib42","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2013.12.032","article-title":"Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis","volume":"60","author":"Rodr\u00edguez","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.08.033_bib43","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cgh.2016.07.016","article-title":"REVERSE Investigators. Terlipressin improves renal function and reverses hepatorenal syndrome in patients with systemic inflammatory response syndrome","volume":"15","author":"Wong","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.08.033_bib44","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1572-0241.2008.01828.x","article-title":"An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response","volume":"103","author":"Sharma","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2022.08.033_bib45","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.08.033_bib46","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"Singh","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.08.033_bib47","first-page":"30","article-title":"Noradrenaline is as effective as terlipressin in hepatorenal syndrome type 1: a prospective, randomized trial","volume":"64","author":"Goyal","year":"2016","journal-title":"J\u00a0Assoc Physicians India"},{"key":"10.1016\/j.cgh.2022.08.033_bib48","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12664-018-0876-3","article-title":"Noradrenaline versus terlipressin in the management of type 1 hepatorenal syndrome: a randomized controlled study","volume":"37","author":"Saif","year":"2018","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.cgh.2022.08.033_bib49","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/hep.30208","article-title":"Terlipressin Is superior to noradrenaline in the management of acute kidney injury in acute on chronic liver failure","volume":"71","author":"Arora","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.08.033_bib50","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/lt.26065","article-title":"Feasibility and effectiveness of norepinephrine outside the intensive care setting for treatment of hepatorenal syndrome","volume":"27","author":"Kwong","year":"2021","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2022.08.033_bib51","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Italian Association for the Study of the Liver Study Group on Hepatorenal Syndrome. Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.08.033_bib52","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jcrc.2015.05.006","article-title":"Role of renal replacement therapy in patients with type 1 hepatorenal syndrome receiving combination treatment of vasoconstrictor plus albumin","volume":"30","author":"Zhang","year":"2015","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.cgh.2022.08.033_bib53","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jamasurg.2017.1673","article-title":"Analysis of survival after initiation of continuous renal replacement therapy in a surgical intensive care unit","volume":"152","author":"Tatum","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.cgh.2022.08.033_bib54","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1056\/NEJMra2104090","article-title":"Extracorporeal kidney-replacement therapy for acute kidney injury","volume":"386","author":"Gaudry","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2022.08.033_bib55","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/lt.22008","article-title":"Pre-transplant predictors of recovery after liver transplantation","volume":"16","author":"Northup","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2022.08.033_bib56","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/lt.24049","article-title":"Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation","volume":"21","author":"Wong","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2022.08.033_bib57","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2215\/CJN.09600912","article-title":"Short- term pre-transplant renal replacement therapy and renal non recovery after liver transplantation","volume":"8","author":"Sharma","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cgh.2022.08.033_bib58","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/sdi.12224","article-title":"Is there a role for dialysis in patients with hepatorenal syndrome who are not liver transplant candidates?","volume":"27","author":"Belcher","year":"2014","journal-title":"Semin Dial"},{"key":"10.1016\/j.cgh.2022.08.033_bib59","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jhep.2012.06.024","article-title":"Hepatorenal syndrome, MELD score and liver transplantation: an evolving issue with relevant implications for clinical practice","volume":"57","author":"Angeli","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.08.033_bib60","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.gastro.2010.07.043","article-title":"Prognostic importance of the cause of renal failure in patients with cirrhosis","volume":"40","author":"Martin-Liahl","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.08.033_bib61","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/ajt.12257","article-title":"Predicting end-stage renal disease after liver transplant","volume":"13","author":"Israni","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2022.08.033_bib62","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1097\/TP.0000000000000820","article-title":"Renal function and transplantation in liver disease","volume":"99","author":"Parajuli","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.cgh.2022.08.033_bib63","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1002\/lt.21900","article-title":"Outcomes after liver transplantation: chronic kidney disease","volume":"15","author":"Bahirwani","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2022.08.033_bib64","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/hep.31529","article-title":"Response to terlipressin and albumin is associated with improved liver transplant outcomes in patients with hepatorenal syndrome","volume":"73","author":"Piano","year":"2021","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cgh.2022.08.033_bib65","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.transproceed.2008.02.062","article-title":"Impact of renal failure on liver transplantation survival","volume":"40","author":"Afonso","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cgh.2022.08.033_bib66","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/lt.22008","article-title":"Pretransplant predictors of recovery of renal function after liver transplantation","volume":"16","author":"Northup","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2022.08.033_bib67","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ndt\/gfi212","article-title":"The course of type 1 hepato-renal syndrome post liver transplantation","volume":"21","author":"Marik","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cgh.2022.08.033_bib68","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00007890-199102000-00030","article-title":"Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome-experience in 300 patients","volume":"51","author":"Gonwa","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.cgh.2022.08.033_bib69","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/2050640617707089","article-title":"Outcome and natural course of renal dysfunction in liver transplant recipients with severely impaired kidney function prior to transplantation","volume":"6","author":"Horvatits","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.cgh.2022.08.033_bib70","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-0012.2010.01238.x","article-title":"High mortality in orthotopic liver transplant recipients who require hemodialysis","volume":"25","author":"Zand","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cgh.2022.08.033_bib71","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1111\/j.1600-6143.2012.04190.x","article-title":"Simultaneous liver-kidney transplantation summit: Current state and future directions","volume":"12","author":"Nadim","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2022.08.033_bib72","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1111\/j.1600-6143.2006.01526.x","article-title":"Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: Where will MELD lead us?","volume":"6","author":"Gonwa","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2022.08.033_bib73","unstructured":"Organ Procurement and Transplantation Network. Policies. Available at: https:\/\/optn.transplant.hrsa.gov\/media\/1200\/optn_policies.pdf. Accessed October 3, 2022."}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356522008291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356522008291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:42:10Z","timestamp":1761543730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356522008291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":73,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1542356522008291"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2022.08.033","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2022.08.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the AGA Institute","name":"copyright","label":"Copyright"}]}}